GB0617116D0 - Method of diagnosis - Google Patents

Method of diagnosis

Info

Publication number
GB0617116D0
GB0617116D0 GBGB0617116.9A GB0617116A GB0617116D0 GB 0617116 D0 GB0617116 D0 GB 0617116D0 GB 0617116 A GB0617116 A GB 0617116A GB 0617116 D0 GB0617116 D0 GB 0617116D0
Authority
GB
United Kingdom
Prior art keywords
keloid
expression
scar
interest
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617116.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0617116.9A priority Critical patent/GB0617116D0/en
Publication of GB0617116D0 publication Critical patent/GB0617116D0/en
Priority to US12/439,278 priority patent/US20090305279A1/en
Priority to AU2007291074A priority patent/AU2007291074A1/en
Priority to PCT/GB2007/003221 priority patent/WO2008025961A2/en
Priority to CA002661699A priority patent/CA2661699A1/en
Priority to EP07789310A priority patent/EP2059611A2/en
Priority to ZA200900638A priority patent/ZA200900638B/xx
Priority to JP2009526164A priority patent/JP2010502177A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0617116.9A 2006-08-31 2006-08-31 Method of diagnosis Ceased GB0617116D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0617116.9A GB0617116D0 (en) 2006-08-31 2006-08-31 Method of diagnosis
US12/439,278 US20090305279A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
AU2007291074A AU2007291074A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
PCT/GB2007/003221 WO2008025961A2 (en) 2006-08-31 2007-08-28 Method of diagnosis
CA002661699A CA2661699A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
EP07789310A EP2059611A2 (en) 2006-08-31 2007-08-28 Method of diagnosis
ZA200900638A ZA200900638B (en) 2006-08-31 2007-08-28 Method of diagnosis
JP2009526164A JP2010502177A (ja) 2006-08-31 2007-08-28 診断方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617116.9A GB0617116D0 (en) 2006-08-31 2006-08-31 Method of diagnosis

Publications (1)

Publication Number Publication Date
GB0617116D0 true GB0617116D0 (en) 2006-10-11

Family

ID=37137073

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617116.9A Ceased GB0617116D0 (en) 2006-08-31 2006-08-31 Method of diagnosis

Country Status (8)

Country Link
US (1) US20090305279A1 (enExample)
EP (1) EP2059611A2 (enExample)
JP (1) JP2010502177A (enExample)
AU (1) AU2007291074A1 (enExample)
CA (1) CA2661699A1 (enExample)
GB (1) GB0617116D0 (enExample)
WO (1) WO2008025961A2 (enExample)
ZA (1) ZA200900638B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013144672A1 (en) * 2012-03-30 2013-10-03 Société De Développement Et De Recherche Industrielle Method and kit for the classification and prognosis of wounds
US8877185B2 (en) 2012-05-10 2014-11-04 Stan S. Sastry Managing and treating keloids
KR101943434B1 (ko) * 2015-06-26 2019-01-30 순천향대학교 산학협력단 켈로이드 조직 진단용 바이오 마커 조성물 및 이를 포함하는 키트
KR101667900B1 (ko) * 2016-01-15 2016-10-21 테고사이언스 (주) 켈로이드성 피부 또는 켈로이드 흉터 진단용 바이오마커 단백질 및 이의 이용
CN109917140A (zh) * 2019-04-09 2019-06-21 潍坊市康华生物技术有限公司 一种柯萨奇病毒A6型和A10型IgM抗体联合检测的试剂条及其制备方法
CN115616215A (zh) * 2021-07-13 2023-01-17 上海交通大学医学院附属第九人民医院 一种瘢痕诊断试剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7180198A (en) * 1996-11-12 1998-06-03 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
WO2003097615A1 (en) * 2002-05-17 2003-11-27 Scios, Inc. TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS
CN1323165C (zh) * 2003-05-26 2007-06-27 北京大学第三医院 瘢痕疙瘩与增生性瘢痕差异表达基因文库及其构建方法

Also Published As

Publication number Publication date
WO2008025961A3 (en) 2008-05-02
JP2010502177A (ja) 2010-01-28
ZA200900638B (en) 2010-04-28
US20090305279A1 (en) 2009-12-10
EP2059611A2 (en) 2009-05-20
WO2008025961A2 (en) 2008-03-06
CA2661699A1 (en) 2008-03-06
AU2007291074A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
WO2008069906A3 (en) Digital expression of gene analysis
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2009075799A3 (en) Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
WO2009113779A3 (ko) Ｓｎｐ 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법
WO2013033629A3 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2007082099A3 (en) Gene expression markers for colorectal cancer prognosis
EP2021534A4 (en) ESTIMATE AND REDUCE THE RISK OF GRAFT VERSUS HOST REACTION
WO2010051314A3 (en) Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
WO2011070441A3 (en) Categorization of dna samples
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
WO2009086215A3 (en) Pathway analysis of cell culture phenotypes and uses thereof
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2008025961A3 (en) Method of diagnosis
WO2010035140A8 (en) Method for analyzing d4z4 tandem repeat arrays of nucleic acid and kit therefore
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2009151757A3 (en) Method and apparatus for forensic screening
WO2007039234A3 (en) Methods and nucleic acids for the analysis of gene expression associated with tissue classification
WO2008025963A3 (en) Method of diagnosis
WO2008157299A3 (en) Differential expression profiling analysis of cell culture phenotypes and uses thereof
WO2005070086A3 (en) Methods and compositions for determining a graft tolerant phenotype in a subject
WO2009076229A3 (en) Methods to determine if a subject will respond to a bcr-abl inhibitor
EP2383349A3 (en) Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium using the same
WO2008025968A3 (en) Method of prognosis
WO2009049257A9 (en) Predictive models and methods for diagnosing and assessing coronary artery disease
JP2010502177A5 (enExample)

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)